Aker BioMarine ASA (AKBM)
Market Closed
2 Mar, 14:20
XOSL 
kr
100. 40
+0.2
+0.2%
kr
5.26B Market Cap
- P/E Ratio
180% Div Yield
11,218 Volume
- Eps
kr 100.2
Previous Close Day Range
97.6 100.4
Year Range
43.65 110
Want to track AKBM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AKBM earnings report is expected in 56 days (28 Apr 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 0.04 | - |
| | | - | - |
| | | 0.03 | - |
| | | 0.05 | - |
| | | - | - |
| | | 0.01 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 1.21 | 25.34 |
| | | 0.38 | 0.33 |
| | | - | - |
| | | 0.04 | 0.18 |
| | | 0.03 | 0.01 |
AKBM Earnings Reports FAQ
What is the earnings per share (EPS) for AKBM?
EPS data for AKBM is currently not available, as Aker BioMarine ASA has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 2 years, the earnings growth rate has been approximately 253,256%, reflecting the AKBM's performance and XOSL market conditions.
When is the next earnings release date?
The next earnings release is expected to be on 2026-04-28, based on the AKBM's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Aker BioMarine ASA are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for AKBM at this time, as Aker BioMarine ASA has no recent EPS data to calculate it.
